Solvency II: to delay or not to delay?

Personal lines to drive improved US P&C market profitability this year

But Swiss Re's economists have said commercial lines face uncertainty

Potential "extremist" European Parliament threatens pro-insurer legislation

MEP Isabel Benjumea also critiques Europe's constant regulatory review approach

Saga's interim risk director Stephen Wilcox names his successor

Insurance Europe sets out its stall for level 2 and 3 Solvency II texts

Key technical details to be decided by European Commission

European Parliament plenary passes Solvency II reforms and IRRD

RIS also approved to enter trilogue talks